[Case Study] Takashi Ueda “Candidemia Requires Routine Ophthalmologic Evaluation!” (AMR Alliance Japan, November 18, 2021)
date : 11/18/2021
Tags: AMR
As part of the Alliance’s project to promote antimicrobial steward among medical professionals, AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) has begun publishing case studies from various experts related to antimicrobial resistance.
Takashi Ueda (Department of Infection Control and Prevention, Hyogo College of Medicine Hospital) reports a case titled “Candidemia Requires Routine Ophthalmologic Evaluation!”
Case study 03
Dr. Takashi Ueda (Department of Infection Control and Prevention, Hyogo College of Medicine Hospital)
“Candidemia Requires Routine Ophthalmologic Evaluation!”
For further information, please see the case study below.
Case study 01
Dr. Keiji Okinaka (Director of Infection Control and Prevention Section, National Cancer Center Hospital East / Department of General Internal Medicine, National Cancer Center Hospital East /Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital)
“A disseminated filamentous fungal infection that broke through echinocandin antifungal treatment”
Top Research & Recommendations Posts
- [Public Comment Submission] “The 7th Science, Technology and Innovation Basic Plan” (Draft) (February 19, 2026)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Policy Recommendations in the Field of Blood Disorders “Building a Healthcare Ecosystem Centered on Patients and Those Affected” (April 13, 2026)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Event Report and Discussion Points] AI Diagnostic Support Project Expert Meeting: “The Roles of Industry, Government, Academia, and Civil Society in the Era of AI-Assisted Diagnosis” (May 25, 2026)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Policy Recommendations] Dementia Project “The Future of Dementia Policy Surrounding Families and Others Who Care for People with Dementia” (April 27, 2026)
Featured Posts
-
2026-05-13
[Registration Open] HGPI Salon 2025-2026 Looking Ahead to the Future of Japan’s Social Security System “Session 5: The Value of Healthcare in Society – Perspectives from the Reiwa Era” (June 29, 2026)
-
2026-05-15
[Registration Open] (Webinar) The 2nd J-PEP Seminar – A New Framework for Providing Information on Clinical Trial Participant Recruitment – Legal Points to Consider from the Perspective of Meaningful Involvement (June 15, 2026)
-
2026-05-18
[Registration Open] Kick-off Panel Discussion “From Japan and Africa, in Discussion with the World: Cultivating Together a Philosophical Dialogue on Health” (June 15, 2026)
-
2026-05-19
[Registration Open] (Webinar) HGPI Special Seminar “Building a Society Where People Live with Blood Disorders: The Future of Blood Disorder Policy as Examined from the Frontlines of Home-Based Care × Lived Experience Research” (June 12, 2026)
-
2026-06-04
[Registration Open] (Webinar) The 3rd J-PEP Seminar “Social Participation of People with Intractable Diseases and the Potential of a New Way of Working — ‘RD Workers’ — Lessons from Policy Advocacy Practice” (July 22, 2026)



